Effect of silver nanoparticles on splenocyte activity and selected cytokine levels in the mouse serum

• Autorzy: Malaczewska J.
• Języki publikacji: EN

Abstrakty

EN

The objective of this study was to determine the effect of a nonionic silver nanocolloid administered orally for 7 or 14 d at three concentration levels (25 ppm, 2.5 ppm, and 0.25 ppm) on the phagocytic activity and mitogenic response of splenocytes, and levels of selected cytokines in the serum of NMRI mice. The phagocytic activity of splenocytes was determined by respiratory burst activity and potential killing activity tests, mitogenic response was measured using the MTT assay, and serum levels of IL-lß, IL-6, IL-10, IL-12 p70, and TNF-α were determined by ELISA using commercially available reagents. Silver nanoparticles (Ag-NPs) administered at the lowest dose (0.25 ppm) for 7 d enhanced the respiratory burst activity and proliferative response of ConA- stimulated splenocytes. However, when administered for 14 d, low doses of Ag-NPs lowered both: the respiratory burst activity and the potential killing activity of splenocytes (0.25 ppm), elevated the levels of proinflammatory IL-6 and IL-12 (2.5 ppm and 0.25 ppm), and had a beneficial effect only on the proliferation of LPS-stimulated cells (2.5 ppm). Prolonged administration of Ag-NPs was found to have a detrimental effect on healthy organisms, thus necessitating caution in the use of dietary supplements containing silver nanoparticles.

• Wydawca: -
• Czasopismo: Bulletin of the Veterinary Institute in Puławy
• Rocznik: 2011
• Tom: 55
• Numer: 2
• Opis fizyczny: p.317-322,ref.

Twórcy

autor

Malaczewska J.

• Department of Microbiology and Clinical Immunology, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn,10-719 Olsztyn, Poland

Bibliografia

• 1. Bhol K.C., Alroy J., Schechter P.J.: Anti-inflammatory effect of topical nanocrystalline silver cream on allergic contact dermatitis in a guinea pig model. Clin Exp Dermatol 2004, 29, 282-287.
• 2. Bhol K.C., Schechter P.J.: Topical nanocrystalline silver cream suppresses inflammatory cytokines and induces apoptosis of inflammatory cells in a murine model of allergic contact dermatitis. Br J Dermatol 2005, 152, 1235-1242.
• 3. Chung S., Secombes S.J.: Analysis of events occurring within teleost macrophages during the respiratory burst. Comp Biochem Physiol 1988, 89 B, 539-544.
• 4. Daniel S.C.G.K., Tharmaraj V., Sironmani T. A., Pitchumani K.: Toxicity and immunological activity of silver nanoparticles. Appl Clay Sci 2010, 48, 547-551.
• 5. Dinarello C.A.: Proinflammatory cytokines. CHEST 2000, 118, 503-508.
• 6. Foldbjerg R., Olsen P., Hougaard M., Dang D.A., Hoffmann H.J., Autrup H.: PVP-coated silver nanoparticles and silver ions induced reactive oxygen species, apoptosis and necrosis in THP-1 monocytes. Toxicol Lett 2009, 190, 156-162.
• 7. Greulich C., Kittler S., Epple M., Muhr G., Köller M.: Studies on the biocompatibility and the interaction of silver nanoparticles with human mesenchymal stem cells (hMSCs). Langenbecks Arch Surg 2009, 394, 495-502.
• 8. Luoma S.N.: Silver nanotechnologies and the environment: old problems or new challenges? PEN 15, 2008 (report by Project on Emerging Nanotechnologies; http://www.nanotechproject.org/publications/).
• 9. Mosmann T.: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65, 55-63.
• 10. Nadworny P.L., Wang J.F., Tredget E.E., Burrell R.E.: Anti-inflammatory activity of nanocrystalline silver in a porcine contact dermatitis model. Nanomed Nanotechnol Biol Med 2008, 4, 241-251.
• 11. Park E.J., Yi J., Kim Y., Choi K., Park K.: Silver nanoparticles induce cytotoxicity by a Trojan-horse type mechanism. Toxicol in Vitro 2010, 24, 872-878.
• 12. Pelkonen K.H.O., Heinonen-Tanski H., Hänninen O.O.P.: Accumulation of silver from drinking water into cerebellum and musculus soleus in mice. Toxicology 2003, 186, 151-157.
• 13. Rook G.A., Steele J., Umar S., Dockrell H.M.: A simple method for the solubilisation of reduced NBT and its use as a colorimetric assay for activation of human macrophages by γ-interferon. J Immunol Methods 1985, 82, 161-167.
• 14. Santoro C.M., Duchsherer N.L., Grainger D.W.: Minimal in vitro antimicrobial efficacy and ocular cell toxicity from silver nanoparticles. Nanobiotechnology 2007, 3, 55-65.
• 15. Shin S.H., Ye M.K., Kim H.S., Kang H.S.: The effects of nano-silver on the proliferation and cytokine expression by peripheral blood mononuclear cells. Int Immunopharmacol 2007, 7, 1813-1818.
• 16. Takenaka S., Karg E., Möller W., Roth C., Ziesenis A.: A morphologic study on the fate of ultrafme silver particles: Distribution pattern of phagocytized metallic silver in vitro and in vivo. Inhalation Toxicol 2000, 12, 291-299.
• 17. Takenaka S., Karg E., Roth C., Schulz H., Ziesenis A., Heinzmann U., Schramel P., Heyder J.: Pulmonary and systemic distribution of inhaled ultrafme silver particles in rats. Environ Health Perspect 2001, 109, 547-551.
• 18. Tian J., Wong K.K.Y., Ho C.M., Lok C.N., Yu W.Y., Che C.M., Chiu J.F., Tam P.K.H.: Topical delivery of silver nanoparticles promotes wound healing. ChemMedChem 2007, 2, 129-136.
• 19. Yen H.J., Hsu S.H., Tsai C.L.: Cytotoxicity and immunological response of gold and silver nanoparticles of different sizes. Small 2009, 5, 1553-1561.
• 20. Wright J. B., Lam K., Buret A.G., Olson M.E., Burrell R.E.: Early healing events in a porcine model of contaminated wounds: effect of nanocrystalline silver on matrix metalloproteinases, cell apoptosis, and healing. Wound Rep Reg 2002, 10, 141-151.